Skip to main content
Top
Published in: Reproductive Biology and Endocrinology 1/2020

01-12-2020 | Infertility | Research

Do state insurance mandates alter ICSI utilization?

Authors: Pavel Zagadailov, David B. Seifer, He Shan, Shvetha M. Zarek, Albert L. Hsu

Published in: Reproductive Biology and Endocrinology | Issue 1/2020

Login to get access

Abstract

Background

Assisted reproductive technology (ART) insurance mandates resulted in improved access to infertility treatments like intracytoplasmic sperm injection (ICSI). Our objective was to examine whether ART insurance mandates demonstrate an increased association with ICSI use.

Methods

In this retrospective cohort study, clinic-specific data for 2000–2016 from the Centers for Disease Control (CDC) were grouped by state and subgrouped by the presence and extent of ART state insurance mandates. Mandated (n = 8) and non-mandated (n = 22) states were compared for ICSI use and male factor (MF) infertility in fresh non-donor ART cycles with a transfer in women < 35 years. Clinical pregnancy (CPR), live birth (LBR) rates, preimplantation genetic testing (PGT), elective single-embryo transfer (eSET) and twin birth rates per clinic were evaluated utilizing Welch’s t-test. Pearson correlation was used to measure the strength of association between MF and ICSI; ICSI and CPR, and ICSI and LBR over time. Results were considered statistically significant at a p-value of < 0.05, with Bonferroni correction used for multiple comparisons.

Results

From 2000 to 2016, ICSI use per clinic increased in both mandated and non-mandated states. ICSI use per clinic in non-mandated states was significantly greater from 2011 to 2016 (p < 0.05, all years) than in mandated states. Clinics in mandated states had less MF (30.5 ± 15% vs 36.7 ± 15%; p < 0.001), lower CPR (39.8 ± 4% vs 43.4 ± 4%; p = 0.02) and lower LBR (33.9 ± 3.5% vs 37.9 ± 3.5%; p < 0.05). PGT rates were not significantly different. ICSI use in non-mandated states correlated with MF rates (r = 0.524, p = 0.03). A significant correlation between ICSI and CPR (r = 0.8, p < 0.001) and LBR (r = 0.7, p < 0.001) was noted in mandated states only. eSET rates were greater and twin rates were lower in mandated compared with non-mandated states.

Conclusions

There was greater use of ICSI per clinic in non-mandated states, which correlated with an increased frequency of MF. In mandated states, lower ICSI rates per clinic were accompanied by a positive correlation with CPR and LBR, as well as a trend for greater eSET rates and lower twin rates, suggesting that state mandates for ART coverage may encourage more selective utilization of laboratory resources.
Appendix
Available only for authorised users
Literature
1.
go back to reference Provost MP, Thomas SM, Yeh JS, Hurd WW, Eaton JL. State insurance mandates and multiple birth rates after in vitro fertilization. Obstet Gynecol. 2016;128:1205–14.CrossRef Provost MP, Thomas SM, Yeh JS, Hurd WW, Eaton JL. State insurance mandates and multiple birth rates after in vitro fertilization. Obstet Gynecol. 2016;128:1205–14.CrossRef
13.
go back to reference Pfeifer S, Fritz M, Goldberg J, McClure RD, Lobo R, Thomas M, et al. Practice committees of the American Society for Reproductive Medicine and Society for Assisted Reproductive Technology. Intracytoplasmic sperm injection (ICSI) for non-male factor infertility: a committee opinion. Fertil Steril. 2012;98(6):1395–9.CrossRef Pfeifer S, Fritz M, Goldberg J, McClure RD, Lobo R, Thomas M, et al. Practice committees of the American Society for Reproductive Medicine and Society for Assisted Reproductive Technology. Intracytoplasmic sperm injection (ICSI) for non-male factor infertility: a committee opinion. Fertil Steril. 2012;98(6):1395–9.CrossRef
14.
go back to reference Jain T, Gupta RS. Trends in the use of intracytoplasmic sperm injection in the United States. N Engl J Med. 2007;357(3):251–7.CrossRef Jain T, Gupta RS. Trends in the use of intracytoplasmic sperm injection in the United States. N Engl J Med. 2007;357(3):251–7.CrossRef
15.
go back to reference Dieke AC, Mehta A, Kissin DM, Nangia AK, Warner L, Boulet SL. Intracytoplasmic sperm injection use in states with and without insurance coverage mandates for infertility treatment, United States, 2000-2015. Fertil Steril. 2018;109(4):691–7.CrossRef Dieke AC, Mehta A, Kissin DM, Nangia AK, Warner L, Boulet SL. Intracytoplasmic sperm injection use in states with and without insurance coverage mandates for infertility treatment, United States, 2000-2015. Fertil Steril. 2018;109(4):691–7.CrossRef
16.
go back to reference Zagadailov P, Hsu A, Seifer DB, Stern JE. Differences in utilization of intracytoplasmic sperm injection (ICSI) within human services (HHS) regions and metropolitan megaregions in the U.S. Reprod Biol Endocrinol. 2017;15(1):45.CrossRef Zagadailov P, Hsu A, Seifer DB, Stern JE. Differences in utilization of intracytoplasmic sperm injection (ICSI) within human services (HHS) regions and metropolitan megaregions in the U.S. Reprod Biol Endocrinol. 2017;15(1):45.CrossRef
17.
go back to reference Zagadailov P, Hsu A, Stern JE, Seifer DB. Temporal differences in utilization of intracytoplasmic sperm injection among U.S. regions. Obstet Gynecol. 2018;132(2):310–20.CrossRef Zagadailov P, Hsu A, Stern JE, Seifer DB. Temporal differences in utilization of intracytoplasmic sperm injection among U.S. regions. Obstet Gynecol. 2018;132(2):310–20.CrossRef
21.
go back to reference Cox GF, Bürger J, Lip V, et al. Intracytoplasmic sperm injection may increase the risk of imprinting defects. Am J Hum Genet. 2002;71(1):162–4.CrossRef Cox GF, Bürger J, Lip V, et al. Intracytoplasmic sperm injection may increase the risk of imprinting defects. Am J Hum Genet. 2002;71(1):162–4.CrossRef
22.
go back to reference Practice Committee of the American Society for Reproductive Medicine, Practice Committee of the Society for Assisted Reproductive Technology. Genetic considerations related to intracytoplasmic sperm injection (ICSI). Fertil Steril. 2008;90(5 Suppl):S182–4. Practice Committee of the American Society for Reproductive Medicine, Practice Committee of the Society for Assisted Reproductive Technology. Genetic considerations related to intracytoplasmic sperm injection (ICSI). Fertil Steril. 2008;90(5 Suppl):S182–4.
23.
go back to reference Wen J, Jiang J, Ding C, et al. Birth defects in children conceived by in vitro fertilization and intracytoplasmic sperm injection: a meta-analysis. Fertil Steril. 2012;97(6):1331–7.CrossRef Wen J, Jiang J, Ding C, et al. Birth defects in children conceived by in vitro fertilization and intracytoplasmic sperm injection: a meta-analysis. Fertil Steril. 2012;97(6):1331–7.CrossRef
24.
go back to reference Ferraretti AP, Goossens V, Kupka M, et al. Assisted reproductive technology in Europe, 2009: results generated from European registers by ESHRE. Hum Reprod. 2013;28(9):2318–31.CrossRef Ferraretti AP, Goossens V, Kupka M, et al. Assisted reproductive technology in Europe, 2009: results generated from European registers by ESHRE. Hum Reprod. 2013;28(9):2318–31.CrossRef
Metadata
Title
Do state insurance mandates alter ICSI utilization?
Authors
Pavel Zagadailov
David B. Seifer
He Shan
Shvetha M. Zarek
Albert L. Hsu
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Reproductive Biology and Endocrinology / Issue 1/2020
Electronic ISSN: 1477-7827
DOI
https://doi.org/10.1186/s12958-020-00589-w

Other articles of this Issue 1/2020

Reproductive Biology and Endocrinology 1/2020 Go to the issue